Schoch Charles 4
4 · Candel Therapeutics, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
Schoch Charles
Chief Financial Officer
Transactions
- Award
Common Stock
2025-06-25$4.67/sh+5,353$24,999→ 43,391 total
Footnotes (1)
- [F1]Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.